MarketInOut Stock Screener Log In | Sign Up
 

Alkem Laboratories Ltd

BSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 09/11/2026 15:50
Alkem Laboratories Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeBSE
Market Capitalization614,564 mln
Float46.14 mln
Earnings Date11/13/2026

EPS

180
Exceptional

P / E

28.20
Elevated

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-2.2
Caution advised

1-Year Forecast

5,949
Attractive

Relative Strength

27 / 100
Underperforming

Business Description

Founded in 1973 and based in Mumbai, Alkem Laboratories is an Indian pharmaceutical company that develops, makes, and sells a wide range of medicines and health products across India, the United States, and other global markets. Its portfolio spans branded and generic drugs, active pharmaceutical ingredients, biosimilars, and nutritional supplements covering dozens of medical conditions from infections and digestive disorders to cancer and heart disease. The company also offers everyday health products such as vitamins, cough syrups, and personal care items.

Key Fundamentals

EPS180
P/E28.20
ROE16.53
RPS1,261
ROIC15.72
ROA11.00
Interest Cover14.85
EBITDA, mln34,441
EV / EBITDA18.16
EV / EBIT20.51
Revenue, mln150,813
EV / Revenue4.15

Financial Strength

Altman Z-Score8.3
Piotroski F-Score 4 / 9
Beneish M-Score-2.2
Price to Intrinsic Value2.44
Price to Lynch Fair Value2.01
Price to Graham Number2.42
1-Year Target Price5,949
Shiller PE Ratio37.64

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -1.87% 45 / 100   
1 Month -6.08% 28 / 100   
2 Months -4.22% 36 / 100   
6 Months -9.26% 24 / 100   
1 Year -3.1% 60 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us